heterogeneous vancomycin-intermediate S. aureus
Vancomycin Susceptibility Trends and Prevalence of Heterogeneous Vancomycin Intermediate Staphylococcus aureus in Clinical Methicillin Resistant S aureus Isolates
6
Clinical and Laboratory Characteristics of Invasive Infections Due to Methicillin Resistant Staphylococcus aureus Isolates Demonstrating a Vancomycin MIC of 2 Micrograms per Milliliter: Lack of Effect of Heteroresistant Vancomycin Intermediate S aureus Phenotype
5
Detection of Staphylococcus aureus Isolates with Heterogeneous Intermediate Level Resistance to Vancomycin in the United States
5
Heteroresistant vancomycin-intermediate <em>Staphylococcus aureus</em> (hVISA) in prosthetic joint infections: a case series and review
6
Evaluation of a New Etest Vancomycin Teicoplanin Strip for Detection of Glycopeptide Intermediate Staphylococcus aureus (GISA), in Particular, Heterogeneous GISA
6
Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate <em>Staphylococcus aureus</em>
11
Characterization of heterogeneous vancomycin intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus
7
Prevalence, Molecular Epidemiology, and Clinical Significance of Heterogeneous Glycopeptide Intermediate Staphylococcus aureus in Liver Transplant Recipients
6
Evolution of a Vancomycin Intermediate Staphylococcus aureus Strain In Vivo: Multiple Changes in the Antibiotic Resistance Phenotypes of a Single Lineage of Methicillin Resistant S aureus under the Impact of Antibiotics Administered for Chemotherapy
7
Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study
7
The Presence of Heterogeneous Vancomycin Intermediate Staphylococcus aureus (heteroVISA) in a Major Malaysian Hospital
5
Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina
6
Accuracy of Commercial and Reference Susceptibility Testing Methods for Detecting Vancomycin Intermediate Staphylococcus aureus
5
PubMedCentral-PMC5075054.pdf
8
Asymptomatic colonization of Staphylococcus aureus with intermediate resistance to vancomycin harboring vanB resistance gene
8
Determining the clinical significance of co-colonization of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in the intestinal tracts of patients in intensive care units: a case–control study
9
Bacteremia and Infective Endocarditis Caused by a Non Daptomycin Susceptible, Vancomycin Intermediate, and Methicillin Resistant Staphylococcus aureus Strain in Taiwan
5
Comparative Genomics of Vancomycin Resistant Staphylococcus aureus Strains and Their Positions within the Clade Most Commonly Associated with Methicillin Resistant S aureus Hospital Acquired Infection in the United States
9
Relationship between Vancomycin Resistant Staphylococcus aureus, Vancomycin Intermediate S aureus, High Vancomycin MIC, and Outcome in Serious S aureus Infections
5
Antibiotic Management of Staphylococcus aureus Infections in US Children's Hospitals, 1999–2008
9